Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Aug 24:8:2237-42.
doi: 10.2147/OTT.S88908. eCollection 2015.

Comparing two assays for clinical genomic profiling: the devil is in the data

Rachel M Squillace  1 , Garrett M Frampton  1 , Phil J Stephens  1 , Jeffrey S Ross  1 , Vincent A Miller  1
Affiliations

Comparing two assays for clinical genomic profiling: the devil is in the data

Rachel M Squillace et al. Onco Targets Ther. .
No abstract available

PubMed Disclaimer

References

    1. Weiss GJ, Hoff BR, Whitehead RP, et al. Evaluation and comparison of two commercially available targeted next-generation sequencing platforms to assist oncology decision making. Onco Targets Ther. 2015;8:959–967. - PMC - PubMed
    1. Frampton GM, Fichtenholtz A, Otto GA, et al. Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing. Nat Biotechnol. 2013;31(11):1023–1031. - PMC - PubMed
    1. Marsh DJ, Trahair TN, Martin JL, et al. Rapamycin treatment for a child with germline PTEN mutation. Nat Clin Pract Oncol. 2008;5(6):357–361. - PubMed
    1. Cheng H, Piperdi B, Zou Y, et al. 335 RICTOR amplification as a novel molecular target for the treatment of lung cancer. Eur J Cancer. 2014;50(Suppl 6):108–109.
    1. Borad MJ, Champion MD, Egan JB, et al. Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma. PLoS Genet. 2014;10(2):e1004135. - PMC - PubMed